著者

中井 清人 河原 敦

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.37, no.3, pp.133-143, 2011 (Released:2012-04-25)

参考文献数

16

被引用文献数

6 5

---

Pharmacists in the United States perform a wider range of occupational functions,and have greater authority than thosein Japan.Possible reasons for this are that they provide specific evidence of clinical benefits for patients and contribute toreducing medical costs through their involvement in clinical activities.The legal basis for their wider range of functions andgreater authority is defined in Collaborative Drug Therapy Management (CDTM) in the law that authorizes pharmacists totake part in the management of drug therapy and other tasks in accordance with a prior written agreement between physiciansand them.We recently investigated laws and regulations in the states that have introduced CDTM in order to examine the legal basisdefined in it for the wide range of occupational functions of pharmacists in the US,agreements on CDTM,and qualificationsof and requirements for pharmacists who take part in CDTM.We found that although different state laws have differentprovisions,there were no substantial differences among them regarding the basic structure of CDTM.In addition,publicly-available protocols actually used in the clinical setting were obtained from 3 institutions and examinedto determine how pharmacists and physicians reached agreement on the planning and implementation of CDTM,andthe drug therapies they provided according to different protocols,and the protocols were compared.All of them had thesame basic concept of CDTM and were prepared according to the joint statement of ACP and ASTM.

著者

中井 清人

出版者

日本社会薬学会

雑誌

社会薬学 (ISSN:09110585)

巻号頁・発行日

vol.36, no.1, pp.36-38, 2017-06-10 (Released:2017-06-20)

参考文献数

3

被引用文献数

3

---

Aging society has been progressed in Japan, so that it is projected that one in four is an elderly person and that demands of medical and nursing care show a marked increase in the near future. The Japanese Ministry of Health, Labor and Welfare (MHLW) targets to create the Integrated Community Care System (ICCS) in each community to realize every person can live a life with dignity even in the progressive aging society by 2025 when the demands of medical and nursing care will be jumped up caused by the baby boom generation will reach their age of 75. In the ICCS, the function and role of pharmacies/pharmacists are expected to be different from the current ones. Therefore, pharmacies/pharmacists have to find their appropriate function and role in the ICCS, and also have to adapt themselves smoothly to the progressive aging society even though no one in the world has an experience.The MHLW introduced Pharmacy Vision for Patients on October of 2015, and also has established the new pharmacy reimbursement program “Your Pharmacist Reimbursed Program” on April of 2016 as the first step to cope with the progressive aging society at 2025. In this manuscript, I will introduce the new MHLW policies for Pharmacies/pharmacists. And also I will consider the needs for pharmacies/pharmacists and the function and role that they have to fulfill in the ICCS.

著者

河原 敦 中井 清人 倉田 なおみ 亀井 美和子

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.41, no.6, pp.435-441, 2015-06-10 (Released:2016-06-10)

参考文献数

26

---

The role of pharmacists in the US that have advanced functions compared to the traditional pharmacists is based on the collaborative drug therapy management (CDTM). Recently in Japan, the importance of enhancing the team approach whose concept is to make the best use of the each health providers' expertise has been discussed in the health care society. As regards pharmacists, pharmacists' pivotal role in medication therapy management is in great demand in the discussion. On the other hand, pharmacists are more exposed to a litigation risk as pharmacists sometimes are sued for their medical negligence these days.In this manuscript, we conducted a literature and case review for pharmacist responsibility conducting the CDTM in the US. However, we could not find reports and cases, though a litigation risk for pharmacists has been enhanced with the pharmacist role expanding in the CDTM. Furthermore, we conducted a literature and case review for nurse practitioner (NP) as well. As a result, in some cases, NP's negligence was judged independently by the action of NP was whether appropriate or not with no consideration for physician's supervise, and the supervising or collaborating physician's negligence was judged according to the physician's action in the consultation is appropriate or not. As the number of litigation for NP increased, nurse societies raised so many opinions on how to judge appropriately such as which the standard of care (SOC) for physicians or for NPs was applicable and as whether a physician might have an expert witness qualification.

著者

中井 清人

雑誌

第53回日本薬剤師会学術大会

巻号頁・発行日

2020-09-03